-
In category Press releasesFinnish research expertise utilizing national register data produces internationally unique information
The results of pragmatic FinFluHD influenza trial conducted in Finland have been published in a peer-reviewed “Influenza and Other Respiratory Viruses” journal. The trial evaluated the effectiveness of the high-dose flu vaccine in people over 65 years of age. The goal of the FinFluHD trial was to find out whether a high-dose vaccine containing four […]
-
In category BlogVaccine development thrives – Finland offers unique possibilities
Finland has strong expertise in high-quality vaccine research based on decades of experience. In addition, exceptional national data resources increase the attractiveness of Finland for international research investments. When the overall impact of vaccines is studied on a large scale, in addition to clinical trials aimed at obtaining a license for marketing authorization, important evidence […]